Elizabeth Bayliss
Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deprescriptions | 17 | 2025 | 34 | 8.280 |
Why?
| | Dementia | 14 | 2025 | 302 | 4.160 |
Why?
| | Chronic Disease | 32 | 2024 | 1812 | 3.980 |
Why?
| | Multiple Chronic Conditions | 13 | 2025 | 34 | 2.930 |
Why?
| | Cognitive Dysfunction | 7 | 2024 | 451 | 2.540 |
Why?
| | Patient Portals | 5 | 2024 | 49 | 2.390 |
Why?
| | Primary Health Care | 24 | 2025 | 1710 | 2.380 |
Why?
| | Comorbidity | 23 | 2018 | 1646 | 2.130 |
Why?
| | Patient-Centered Care | 8 | 2021 | 540 | 1.820 |
Why?
| | Polypharmacy | 9 | 2025 | 92 | 1.760 |
Why?
| | Delivery of Health Care | 9 | 2025 | 940 | 1.640 |
Why?
| | Patient Care Team | 9 | 2019 | 686 | 1.630 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 4 | 2024 | 257 | 1.630 |
Why?
| | Aged | 73 | 2025 | 25850 | 1.500 |
Why?
| | Aged, 80 and over | 37 | 2025 | 8243 | 1.430 |
Why?
| | Electronic Health Records | 8 | 2025 | 1169 | 1.360 |
Why?
| | Potentially Inappropriate Medication List | 4 | 2024 | 16 | 1.290 |
Why?
| | Physicians, Primary Care | 7 | 2019 | 206 | 1.270 |
Why?
| | Caregivers | 14 | 2025 | 1047 | 1.250 |
Why?
| | Delivery of Health Care, Integrated | 6 | 2021 | 297 | 1.240 |
Why?
| | Health Status | 8 | 2019 | 833 | 1.240 |
Why?
| | Quality of Life | 16 | 2022 | 3166 | 1.140 |
Why?
| | Safety-net Providers | 3 | 2021 | 124 | 1.120 |
Why?
| | Communication | 9 | 2025 | 961 | 1.070 |
Why?
| | Depressive Disorder | 4 | 2012 | 374 | 1.070 |
Why?
| | Continuity of Patient Care | 4 | 2019 | 287 | 1.020 |
Why?
| | Inappropriate Prescribing | 2 | 2024 | 63 | 1.010 |
Why?
| | Female | 87 | 2025 | 77976 | 0.970 |
Why?
| | Male | 85 | 2025 | 72035 | 0.960 |
Why?
| | Quality of Health Care | 4 | 2021 | 688 | 0.950 |
Why?
| | Self Care | 6 | 2012 | 388 | 0.940 |
Why?
| | Humans | 121 | 2025 | 144261 | 0.920 |
Why?
| | Polypharmacology | 1 | 2025 | 2 | 0.910 |
Why?
| | Qualitative Research | 15 | 2025 | 1659 | 0.820 |
Why?
| | Mental Disorders | 6 | 2020 | 1138 | 0.810 |
Why?
| | Chronic Pain | 2 | 2022 | 290 | 0.810 |
Why?
| | Health Services | 2 | 2017 | 114 | 0.800 |
Why?
| | Benzodiazepines | 1 | 2024 | 165 | 0.790 |
Why?
| | Gastric Bypass | 2 | 2014 | 124 | 0.750 |
Why?
| | Attitude of Health Personnel | 5 | 2017 | 1182 | 0.740 |
Why?
| | Health Status Indicators | 2 | 2014 | 165 | 0.730 |
Why?
| | United States | 32 | 2025 | 15876 | 0.710 |
Why?
| | Cholinergic Antagonists | 2 | 2019 | 23 | 0.690 |
Why?
| | Retrospective Studies | 30 | 2024 | 17009 | 0.670 |
Why?
| | Colorado | 17 | 2025 | 4562 | 0.660 |
Why?
| | Food Supply | 1 | 2021 | 89 | 0.660 |
Why?
| | Health Plan Implementation | 2 | 2019 | 136 | 0.650 |
Why?
| | Patient Education as Topic | 2 | 2025 | 777 | 0.650 |
Why?
| | Self Efficacy | 3 | 2019 | 411 | 0.630 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 919 | 0.620 |
Why?
| | Cohort Studies | 19 | 2025 | 5935 | 0.620 |
Why?
| | Middle Aged | 44 | 2025 | 35762 | 0.610 |
Why?
| | Medicare Part D | 2 | 2010 | 23 | 0.590 |
Why?
| | Advance Directives | 1 | 2020 | 87 | 0.590 |
Why?
| | Patient Reported Outcome Measures | 4 | 2019 | 487 | 0.590 |
Why?
| | Mental Health Services | 3 | 2019 | 459 | 0.580 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1559 | 0.560 |
Why?
| | Hospitalization | 7 | 2024 | 2424 | 0.560 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 94 | 0.550 |
Why?
| | Documentation | 1 | 2020 | 197 | 0.550 |
Why?
| | Health Services Needs and Demand | 3 | 2015 | 279 | 0.540 |
Why?
| | Telemedicine | 4 | 2024 | 940 | 0.540 |
Why?
| | Hypolipidemic Agents | 3 | 2017 | 86 | 0.540 |
Why?
| | Diabetic Neuropathies | 2 | 2016 | 97 | 0.530 |
Why?
| | Specialization | 2 | 2017 | 134 | 0.520 |
Why?
| | Patient Acceptance of Health Care | 4 | 2021 | 878 | 0.490 |
Why?
| | Time-to-Treatment | 1 | 2018 | 240 | 0.490 |
Why?
| | Maryland | 4 | 2025 | 65 | 0.490 |
Why?
| | Health Maintenance Organizations | 6 | 2012 | 104 | 0.490 |
Why?
| | Medication Adherence | 4 | 2022 | 512 | 0.470 |
Why?
| | Medically Uninsured | 1 | 2017 | 129 | 0.470 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2023 | 2516 | 0.470 |
Why?
| | Medicaid | 2 | 2022 | 461 | 0.470 |
Why?
| | Patient Satisfaction | 4 | 2019 | 704 | 0.470 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1347 | 0.460 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2021 | 1409 | 0.460 |
Why?
| | Self Report | 6 | 2024 | 863 | 0.460 |
Why?
| | Patients | 2 | 2021 | 178 | 0.460 |
Why?
| | Adult | 35 | 2025 | 40262 | 0.460 |
Why?
| | Healthcare Disparities | 2 | 2021 | 725 | 0.450 |
Why?
| | Antihypertensive Agents | 5 | 2019 | 509 | 0.440 |
Why?
| | Health Promotion | 1 | 2021 | 774 | 0.440 |
Why?
| | Sickness Impact Profile | 2 | 2005 | 62 | 0.440 |
Why?
| | Gastroplasty | 1 | 2014 | 32 | 0.430 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 102 | 0.430 |
Why?
| | Bariatric Surgery | 2 | 2015 | 236 | 0.420 |
Why?
| | Pain Management | 2 | 2015 | 405 | 0.420 |
Why?
| | Hypertension | 7 | 2019 | 1254 | 0.410 |
Why?
| | Drug Utilization | 2 | 2012 | 166 | 0.410 |
Why?
| | Diabetes Mellitus | 7 | 2017 | 1092 | 0.410 |
Why?
| | Hypoglycemic Agents | 5 | 2019 | 1379 | 0.410 |
Why?
| | Surveys and Questionnaires | 17 | 2022 | 6021 | 0.400 |
Why?
| | Neuralgia | 1 | 2015 | 144 | 0.400 |
Why?
| | Morbidity | 2 | 2012 | 323 | 0.390 |
Why?
| | Laparoscopy | 2 | 2014 | 475 | 0.390 |
Why?
| | Focus Groups | 5 | 2020 | 569 | 0.390 |
Why?
| | Sleep Deprivation | 1 | 2015 | 206 | 0.380 |
Why?
| | Socioeconomic Factors | 7 | 2020 | 1312 | 0.380 |
Why?
| | Postoperative Care | 1 | 2015 | 288 | 0.380 |
Why?
| | Comparative Effectiveness Research | 1 | 2014 | 169 | 0.380 |
Why?
| | Morphine | 1 | 2013 | 168 | 0.370 |
Why?
| | Preoperative Care | 1 | 2015 | 379 | 0.360 |
Why?
| | Health Services Accessibility | 3 | 2017 | 1091 | 0.360 |
Why?
| | Colorectal Neoplasms | 3 | 2014 | 844 | 0.360 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2012 | 44 | 0.350 |
Why?
| | Osteoarthritis | 3 | 2008 | 195 | 0.350 |
Why?
| | Cluster Analysis | 2 | 2020 | 519 | 0.350 |
Why?
| | Cross-Sectional Studies | 14 | 2023 | 5813 | 0.340 |
Why?
| | International Classification of Diseases | 1 | 2012 | 143 | 0.340 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 434 | 0.330 |
Why?
| | Interviews as Topic | 5 | 2025 | 898 | 0.330 |
Why?
| | Psychotherapy | 1 | 2012 | 186 | 0.330 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2917 | 0.330 |
Why?
| | Antidepressive Agents | 1 | 2012 | 242 | 0.320 |
Why?
| | Office Visits | 3 | 2018 | 90 | 0.320 |
Why?
| | Referral and Consultation | 1 | 2017 | 847 | 0.320 |
Why?
| | Prostatic Neoplasms | 2 | 2014 | 974 | 0.320 |
Why?
| | Obesity | 2 | 2014 | 3057 | 0.320 |
Why?
| | Physician-Patient Relations | 6 | 2019 | 581 | 0.310 |
Why?
| | Risk Assessment | 8 | 2024 | 3637 | 0.310 |
Why?
| | Quality Improvement | 5 | 2020 | 1285 | 0.310 |
Why?
| | Vaccination Refusal | 2 | 2021 | 64 | 0.310 |
Why?
| | Models, Statistical | 1 | 2014 | 677 | 0.300 |
Why?
| | Drug Monitoring | 2 | 2017 | 389 | 0.300 |
Why?
| | Patient Preference | 3 | 2022 | 221 | 0.300 |
Why?
| | Multimorbidity | 2 | 2021 | 61 | 0.290 |
Why?
| | Patient Participation | 5 | 2022 | 429 | 0.290 |
Why?
| | Perception | 3 | 2020 | 377 | 0.290 |
Why?
| | Research | 3 | 2018 | 428 | 0.290 |
Why?
| | Stakeholder Participation | 2 | 2020 | 83 | 0.290 |
Why?
| | Neoplasms | 3 | 2014 | 2870 | 0.280 |
Why?
| | Medicare | 6 | 2023 | 881 | 0.280 |
Why?
| | Analgesics, Opioid | 2 | 2014 | 1131 | 0.270 |
Why?
| | Health Services for the Aged | 1 | 2008 | 70 | 0.270 |
Why?
| | Emergency Service, Hospital | 3 | 2015 | 2301 | 0.270 |
Why?
| | Health Personnel | 3 | 2019 | 742 | 0.260 |
Why?
| | Delphi Technique | 4 | 2018 | 329 | 0.260 |
Why?
| | Disease Progression | 2 | 2015 | 2840 | 0.260 |
Why?
| | Geriatrics | 1 | 2008 | 96 | 0.250 |
Why?
| | Glomerular Filtration Rate | 1 | 2011 | 758 | 0.250 |
Why?
| | Cost of Illness | 2 | 2008 | 319 | 0.250 |
Why?
| | Kidney Diseases | 1 | 2011 | 425 | 0.250 |
Why?
| | Psychometrics | 3 | 2018 | 730 | 0.240 |
Why?
| | Memantine | 1 | 2025 | 18 | 0.240 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2447 | 0.230 |
Why?
| | Cholinesterase Inhibitors | 1 | 2025 | 46 | 0.230 |
Why?
| | Telephone | 2 | 2017 | 174 | 0.230 |
Why?
| | Accidental Falls | 2 | 2019 | 222 | 0.230 |
Why?
| | Pain Measurement | 2 | 2018 | 552 | 0.210 |
Why?
| | Disease Management | 4 | 2017 | 643 | 0.210 |
Why?
| | Patient Compliance | 1 | 2008 | 585 | 0.210 |
Why?
| | Nomograms | 2 | 2014 | 59 | 0.210 |
Why?
| | Single-Payer System | 1 | 2003 | 1 | 0.210 |
Why?
| | National Health Insurance, United States | 1 | 2003 | 4 | 0.210 |
Why?
| | Cardiovascular Diseases | 2 | 2014 | 2134 | 0.210 |
Why?
| | Parents | 3 | 2021 | 1401 | 0.210 |
Why?
| | Managed Care Programs | 2 | 2014 | 136 | 0.210 |
Why?
| | Needs Assessment | 2 | 2025 | 401 | 0.200 |
Why?
| | Multivariate Analysis | 5 | 2013 | 1533 | 0.200 |
Why?
| | Dyslipidemias | 3 | 2019 | 171 | 0.200 |
Why?
| | Natural Language Processing | 1 | 2025 | 103 | 0.200 |
Why?
| | Death | 2 | 2022 | 130 | 0.200 |
Why?
| | Asthma | 2 | 2016 | 1767 | 0.200 |
Why?
| | Health Services Research | 3 | 2017 | 394 | 0.200 |
Why?
| | Pragmatic Clinical Trials as Topic | 2 | 2022 | 132 | 0.200 |
Why?
| | Vaccination | 3 | 2021 | 1422 | 0.200 |
Why?
| | Data Collection | 1 | 2005 | 633 | 0.190 |
Why?
| | Insurance Coverage | 2 | 2018 | 238 | 0.190 |
Why?
| | Health Care Reform | 1 | 2003 | 109 | 0.190 |
Why?
| | Interdisciplinary Communication | 2 | 2014 | 197 | 0.190 |
Why?
| | Attitude | 2 | 2021 | 259 | 0.190 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2024 | 186 | 0.180 |
Why?
| | Pharmacists | 1 | 2025 | 240 | 0.180 |
Why?
| | Prognosis | 4 | 2014 | 4278 | 0.180 |
Why?
| | Physicians | 2 | 2023 | 938 | 0.180 |
Why?
| | Survival Rate | 3 | 2014 | 2088 | 0.170 |
Why?
| | Proxy | 1 | 2021 | 34 | 0.170 |
Why?
| | Patient Care Management | 1 | 2020 | 56 | 0.160 |
Why?
| | Information Storage and Retrieval | 1 | 2021 | 121 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 169 | 0.160 |
Why?
| | Clergy | 1 | 2020 | 10 | 0.160 |
Why?
| | Age Factors | 6 | 2019 | 3313 | 0.160 |
Why?
| | Anti-Vaccination Movement | 1 | 2019 | 3 | 0.160 |
Why?
| | Fee-for-Service Plans | 2 | 2014 | 97 | 0.160 |
Why?
| | Health Surveys | 3 | 2012 | 510 | 0.150 |
Why?
| | Longitudinal Studies | 4 | 2018 | 2926 | 0.150 |
Why?
| | California | 4 | 2025 | 469 | 0.150 |
Why?
| | Southwestern United States | 1 | 2019 | 95 | 0.150 |
Why?
| | Urban Health Services | 1 | 2019 | 70 | 0.150 |
Why?
| | Religion | 1 | 2019 | 65 | 0.150 |
Why?
| | Alzheimer Disease | 1 | 2025 | 619 | 0.150 |
Why?
| | Attitude to Health | 2 | 2015 | 434 | 0.150 |
Why?
| | Interprofessional Relations | 2 | 2013 | 280 | 0.150 |
Why?
| | Residence Characteristics | 1 | 2022 | 376 | 0.150 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 50 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2017 | 5389 | 0.140 |
Why?
| | Time Factors | 5 | 2018 | 7155 | 0.140 |
Why?
| | Child, Preschool | 5 | 2021 | 11774 | 0.140 |
Why?
| | Comprehensive Health Care | 2 | 2017 | 22 | 0.140 |
Why?
| | Contraindications, Drug | 1 | 2018 | 10 | 0.140 |
Why?
| | Research Design | 2 | 2024 | 1129 | 0.140 |
Why?
| | Medical Informatics | 1 | 2019 | 97 | 0.140 |
Why?
| | Vaccines | 2 | 2020 | 389 | 0.140 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 222 | 0.140 |
Why?
| | Models, Theoretical | 1 | 2021 | 582 | 0.130 |
Why?
| | Mastectomy | 1 | 2018 | 162 | 0.130 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 419 | 0.130 |
Why?
| | SEER Program | 2 | 2014 | 224 | 0.130 |
Why?
| | Independent Living | 1 | 2018 | 114 | 0.120 |
Why?
| | Prospective Studies | 5 | 2023 | 7970 | 0.120 |
Why?
| | Case Management | 1 | 2017 | 66 | 0.120 |
Why?
| | Blood Pressure | 3 | 2019 | 1759 | 0.120 |
Why?
| | Young Adult | 6 | 2016 | 13990 | 0.120 |
Why?
| | Electronics | 1 | 2017 | 70 | 0.120 |
Why?
| | General Practice | 1 | 2016 | 32 | 0.120 |
Why?
| | Logistic Models | 5 | 2013 | 2104 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2021 | 529 | 0.120 |
Why?
| | Medication Therapy Management | 1 | 2017 | 73 | 0.120 |
Why?
| | Schools | 1 | 2019 | 452 | 0.120 |
Why?
| | Patient Outcome Assessment | 1 | 2017 | 132 | 0.120 |
Why?
| | Validation Studies as Topic | 1 | 2015 | 23 | 0.120 |
Why?
| | Health Care Costs | 1 | 2019 | 421 | 0.110 |
Why?
| | Adolescent | 6 | 2015 | 22281 | 0.110 |
Why?
| | Metformin | 1 | 2019 | 315 | 0.110 |
Why?
| | Body Mass Index | 2 | 2014 | 2420 | 0.110 |
Why?
| | Risk Factors | 7 | 2024 | 10699 | 0.110 |
Why?
| | Influenza, Human | 1 | 2021 | 615 | 0.110 |
Why?
| | Databases, Factual | 3 | 2025 | 1484 | 0.110 |
Why?
| | Hyperlipidemias | 2 | 2012 | 121 | 0.110 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1461 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 358 | 0.110 |
Why?
| | Infant | 2 | 2021 | 10022 | 0.110 |
Why?
| | United States Agency for Healthcare Research and Quality | 1 | 2014 | 7 | 0.110 |
Why?
| | Proportional Hazards Models | 2 | 2015 | 1322 | 0.100 |
Why?
| | Health Priorities | 1 | 2014 | 42 | 0.100 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 884 | 0.100 |
Why?
| | Health Education | 1 | 2016 | 357 | 0.100 |
Why?
| | Child | 5 | 2021 | 22537 | 0.100 |
Why?
| | Age Distribution | 1 | 2014 | 397 | 0.100 |
Why?
| | Cooperative Behavior | 2 | 2014 | 462 | 0.100 |
Why?
| | Activities of Daily Living | 2 | 2008 | 440 | 0.100 |
Why?
| | Terminally Ill | 1 | 2013 | 41 | 0.090 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 42 | 0.090 |
Why?
| | Postoperative Period | 1 | 2013 | 353 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2017 | 586 | 0.090 |
Why?
| | Information Dissemination | 1 | 2014 | 220 | 0.090 |
Why?
| | Program Evaluation | 1 | 2017 | 946 | 0.090 |
Why?
| | Decision Making | 1 | 2019 | 974 | 0.090 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 336 | 0.090 |
Why?
| | Depression | 3 | 2018 | 1533 | 0.090 |
Why?
| | Diabetes Complications | 1 | 2013 | 220 | 0.090 |
Why?
| | Secondary Prevention | 1 | 2013 | 253 | 0.090 |
Why?
| | Treatment Outcome | 5 | 2025 | 11643 | 0.080 |
Why?
| | Postoperative Complications | 2 | 2014 | 2916 | 0.080 |
Why?
| | Primary Prevention | 1 | 2013 | 219 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2014 | 275 | 0.080 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 151 | 0.080 |
Why?
| | Data Mining | 1 | 2011 | 117 | 0.080 |
Why?
| | Insulin | 2 | 2019 | 2501 | 0.080 |
Why?
| | Pandemics | 3 | 2024 | 1682 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 729 | 0.080 |
Why?
| | Osteoarthritis, Knee | 1 | 2013 | 279 | 0.080 |
Why?
| | Weight Loss | 1 | 2015 | 832 | 0.070 |
Why?
| | Emigrants and Immigrants | 1 | 2012 | 157 | 0.070 |
Why?
| | Prescription Fees | 1 | 2008 | 4 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 2 | 2007 | 95 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3403 | 0.070 |
Why?
| | Poisson Distribution | 1 | 2008 | 78 | 0.070 |
Why?
| | Pain | 1 | 2014 | 777 | 0.070 |
Why?
| | Self Disclosure | 1 | 2008 | 62 | 0.070 |
Why?
| | Drug Utilization Review | 1 | 2008 | 61 | 0.070 |
Why?
| | Eligibility Determination | 1 | 2008 | 68 | 0.070 |
Why?
| | Community Health Services | 1 | 2010 | 232 | 0.070 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2013 | 370 | 0.070 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.070 |
Why?
| | Incidence | 2 | 2014 | 2870 | 0.070 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 463 | 0.070 |
Why?
| | Immunoglobulin G | 1 | 2012 | 893 | 0.070 |
Why?
| | Biomedical Research | 1 | 2014 | 709 | 0.070 |
Why?
| | Treatment Refusal | 1 | 2007 | 98 | 0.060 |
Why?
| | Sex Distribution | 1 | 2007 | 380 | 0.060 |
Why?
| | Odds Ratio | 3 | 2014 | 1072 | 0.060 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 741 | 0.060 |
Why?
| | Opioid-Related Disorders | 1 | 2014 | 576 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2023 | 3842 | 0.060 |
Why?
| | Urban Population | 2 | 2012 | 490 | 0.060 |
Why?
| | Linear Models | 1 | 2007 | 850 | 0.060 |
Why?
| | Chicago | 1 | 2004 | 61 | 0.050 |
Why?
| | Contraceptives, Oral | 1 | 2024 | 37 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1519 | 0.050 |
Why?
| | Los Angeles | 1 | 2004 | 76 | 0.050 |
Why?
| | Boston | 1 | 2004 | 92 | 0.050 |
Why?
| | Mass Screening | 1 | 2013 | 1332 | 0.050 |
Why?
| | Causality | 1 | 2024 | 126 | 0.050 |
Why?
| | Estrogen Replacement Therapy | 1 | 2024 | 143 | 0.050 |
Why?
| | Choice Behavior | 1 | 2005 | 177 | 0.050 |
Why?
| | Self Concept | 1 | 2005 | 252 | 0.050 |
Why?
| | Goals | 1 | 2005 | 180 | 0.050 |
Why?
| | Algorithms | 1 | 2011 | 1834 | 0.050 |
Why?
| | Social Support | 1 | 2007 | 649 | 0.050 |
Why?
| | Medicine | 1 | 2004 | 125 | 0.050 |
Why?
| | Regression Analysis | 1 | 2004 | 998 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 380 | 0.040 |
Why?
| | Internet | 2 | 2019 | 698 | 0.040 |
Why?
| | Cholesterol, LDL | 2 | 2014 | 353 | 0.040 |
Why?
| | Insurance Claim Review | 1 | 2021 | 82 | 0.040 |
Why?
| | Housing | 1 | 2022 | 144 | 0.040 |
Why?
| | Washington | 1 | 2021 | 146 | 0.040 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 527 | 0.040 |
Why?
| | Self-Management | 1 | 2024 | 201 | 0.040 |
Why?
| | Health Expenditures | 1 | 2022 | 194 | 0.040 |
Why?
| | Medical Records | 1 | 2021 | 186 | 0.040 |
Why?
| | Health Care Rationing | 1 | 2020 | 59 | 0.040 |
Why?
| | Assisted Living Facilities | 1 | 2020 | 19 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 53 | 0.040 |
Why?
| | Minority Groups | 1 | 2022 | 277 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2020 | 139 | 0.040 |
Why?
| | Health Behavior | 1 | 2005 | 782 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1867 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2314 | 0.040 |
Why?
| | Medicare Part C | 1 | 2019 | 31 | 0.030 |
Why?
| | Nursing Homes | 1 | 2020 | 172 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2019 | 97 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2007 | 1147 | 0.030 |
Why?
| | Mortality | 1 | 2020 | 371 | 0.030 |
Why?
| | Reference Values | 1 | 2019 | 797 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 292 | 0.030 |
Why?
| | Intention | 1 | 2019 | 183 | 0.030 |
Why?
| | Social Determinants of Health | 1 | 2021 | 299 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 1044 | 0.030 |
Why?
| | Fatigue | 1 | 2018 | 361 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2018 | 267 | 0.030 |
Why?
| | Drug Interactions | 1 | 2017 | 397 | 0.030 |
Why?
| | Automation | 1 | 2016 | 102 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 488 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 727 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2815 | 0.030 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 301 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 623 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2007 | 1304 | 0.020 |
Why?
| | Patient Access to Records | 1 | 2013 | 20 | 0.020 |
Why?
| | Electronic Mail | 1 | 2013 | 61 | 0.020 |
Why?
| | ROC Curve | 1 | 2014 | 612 | 0.020 |
Why?
| | Turkey | 1 | 2012 | 19 | 0.020 |
Why?
| | Etanercept | 1 | 2012 | 60 | 0.020 |
Why?
| | Forecasting | 1 | 2014 | 388 | 0.020 |
Why?
| | London | 1 | 2012 | 45 | 0.020 |
Why?
| | Remote Consultation | 1 | 2013 | 66 | 0.020 |
Why?
| | Mental Health | 1 | 2018 | 776 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2012 | 83 | 0.020 |
Why?
| | Infliximab | 1 | 2012 | 108 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2012 | 163 | 0.020 |
Why?
| | Biomarkers | 2 | 2013 | 4254 | 0.020 |
Why?
| | Anxiety | 1 | 2018 | 1104 | 0.020 |
Why?
| | United Kingdom | 1 | 2012 | 336 | 0.020 |
Why?
| | Reoperation | 1 | 2013 | 629 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2012 | 255 | 0.020 |
Why?
| | Risk | 1 | 2012 | 909 | 0.020 |
Why?
| | Models, Organizational | 1 | 2010 | 143 | 0.020 |
Why?
| | Antirheumatic Agents | 1 | 2012 | 303 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2014 | 789 | 0.020 |
Why?
| | Empathy | 1 | 2010 | 181 | 0.020 |
Why?
| | Aging | 1 | 2018 | 1964 | 0.020 |
Why?
| | Patient Readmission | 1 | 2013 | 756 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1217 | 0.020 |
Why?
| | Holistic Health | 1 | 2007 | 16 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2096 | 0.010 |
Why?
| | Learning | 1 | 2010 | 449 | 0.010 |
Why?
| | CD-ROM | 1 | 2005 | 5 | 0.010 |
Why?
| | Diet, Fat-Restricted | 1 | 2005 | 79 | 0.010 |
Why?
| | Veterans | 1 | 2017 | 1600 | 0.010 |
Why?
| | Computer-Assisted Instruction | 1 | 2005 | 71 | 0.010 |
Why?
| | Nonlinear Dynamics | 1 | 2005 | 95 | 0.010 |
Why?
| | Fruit | 1 | 2005 | 152 | 0.010 |
Why?
| | Vegetables | 1 | 2005 | 170 | 0.010 |
Why?
| | Patient Care Planning | 1 | 2005 | 169 | 0.010 |
Why?
| | Registries | 1 | 2012 | 2382 | 0.010 |
Why?
| | Exercise | 1 | 2005 | 2193 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|